Phase II Clinical Trial of Safety and Immunogenicity of Recombinant Subunit Tuberculosis Vaccine GamTBvac
Clinical trial NCT03878004 · COMPLETED
Trial details
- NCT number
- NCT03878004
- Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2019-12-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.